Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiodarone or verapamil in hospitalized symptomatic COVID-19 patients
2020-001951-42Phase 3Completed
- Sponsor
- Nicolaus Copernicus University
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of amiodarone and verapamil in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Nicolaus Copernicus University. Started Apr 2020; status: completed.
02
Drugs
amiodaroneverapamil
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001951-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001951-42.